RUTH GRIFFITH: Open Payments
NPI 1316611247 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 44 payments from 12 companies in 2025. Trend: 2023 $200 · 2024 $535 · 2025 $818
Food & beverage: $818
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $223 |
| AstraZeneca Pharmaceuticals LP | 6 | $188 |
| Lilly USA, LLC | 9 | $140 |
| Medtronic, Inc. | 1 | $75 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| SHIELD THERAPEUTICS INC | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 8 | $28 |
| Organogenesis Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
Products named: AIRSUPRA, MOUNJARO, QULIPTA, UBRELVY, INTELLIS ADAPTIVESTIM, TRELEGY ELLIPTA, ACCRUFER, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
